Dr. Kristina Pfau discusses her research on pseudoxanthoma elasticum and the initiatives of EURETINA's Young Ophthalmologist and Retina Specialists Committee. Kristina Pfau, MD, FEBO, a consultant ...
Peter Kaiser, MD, from Ocular Therapeutix, introduces OTX-TKI (Axpaxli), a novel tyrosine kinase inhibitor delivered through a proprietary hydrogel platform. This innovative treatment for wet ...
Biomarkers and fine-tuned staging are key to progress in improving retinal care, according to Fanka Gilevska, MD, PhD.
The American Academy of Ophthalmology (AAO) annual meeting and expo are fast approaching on October 18 and will run through October 20 at the Orange County Convention Center West in Orlando. In a ...
The company can now initiate the Opti-GAIN (Optimized Geographic Atrophy INterventional) phase 1/2 clinical trial. The US Food and Drug Administration (FDA) has approved the Investigational New Drug ...
Patricio Schlottmann, MD | Authors | Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal care to improve patient outcomes.
Samuel A. Minaker, MD | Authors | Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal care to improve patient outcomes.
Ultra-high-resolution OCT advances retinal imaging, enabling detailed visualization of disease progression and potential therapeutic effects in eye conditions. Nadia Wahid, MD, a professor of ...
Merck and EyeBio launch a pivotal trial for MK-3000, targeting diabetic macular edema with new treatment options to enhance patient outcomes. On September 4, 2025, Merck and EyeBio announced that the ...
Patricio Schlottmann, MD, Head of Clinical Research, Charles Centro Oftalmológico, Argentina, caught up with Modern Retina during the 2025 European Society of Retina Specialists (EURETINA) held Sept 4 ...
The Eye Care Network spoke with Sebastian Wolf, MD, PhD, and Sophie Bonnin, MD, PhD, who presented new findings from the OCS-05 phase 2 ACUITY trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback